Improving PKU Management
Close
News
Latest News
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
Companies join forces to introduce PKU GOLIKE Plus® 3-16, a breakthrough treatment for phenylketonuria (PKU), in the Middle East.
Read moreWorld Orphan Drug Alliance Welcomes Specialised Therapeutics
Specialised Therapeutics to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA)
Read more